Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01734135 · ClinicalTrials.gov registry record · NA
Provider Notification for High B-type Natriuretic Peptide Values
A NA study, sponsored by VA Palo Alto Health Care System.
- Completed
- Registry status
- NA
- Development phase
- 115
- Enrollment target
NCT01734135: Completed NA study, sponsored by VA Palo Alto Health Care System.
NCT01734135 is a NA study that has completed, run by VA Palo Alto Health Care System. The registered enrollment target is 115 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01734135, a NA study, has completed, sponsored by VA Palo Alto Health Care System.
- COMPLETED
- Registry status
- NA
- Development phase
- 115 participants
- Enrollment target
Study Summary
This proposal examines use of a clinical reminder to the primary provider of patient with a high B type natriuretic peptide but no prior imaging. Electrical Medical Record-based Intervention to Determine whether Clinical Reminders Improve Heart Failure Management in Patients with High BNP Values and Unknown LVEF.
Primary Outcome
numerator: Measurement of left ventricular ejection fraction within 6 months of randomization. denominator: All randomized patients
Interventions
- OTHER Clinical Reminder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2010-10 |
| Est. Completion | 2015-09 |
| Phase | NA |
What the finished NCT01734135 record still lists
NCT01734135 is an interventional study that assigns participants to a tested intervention. The registered 115 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 1 intervention - of which Clinical Reminder is the first listed.
NCT01734135 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01734135 about?
NCT01734135 is a clinical study titled "Provider Notification for High B-type Natriuretic Peptide Values". This proposal examines use of a clinical reminder to the primary provider of patient with a high B type natriuretic peptide but no prior imaging. Electrical Medical Record-based Intervention to Determine whether Clinical Reminders Improve Heart Failure Management in Patients with High BNP Values an...
What is the current status of trial NCT01734135?
This trial is currently completed. It is a NA study. The enrollment target is 115 participants. The study started on 2010-10. Estimated completion is 2015-09.
What interventions are being tested in trial NCT01734135?
The interventions under investigation include: Clinical Reminder (OTHER).
Who is sponsoring clinical trial NCT01734135?
This trial is sponsored by VA Palo Alto Health Care System, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01734135's enrollment target sits among peer trials
115 810th of 2000 higher than 1,190 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02346929 · 115 participants · NA
Hematoma Block for Distal Radius Fracture
- NCT03394365 · 115 participants · Phase 3
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
- NCT03907475 · 115 participants · Phase 2
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
- NCT05086692 · 115 participants · Phase 1
A Beta-only IL-2 ImmunoTherapY Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia